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Abstract
Background: Non-ST-segment elevation myocardial infarction (NSTEMI) has become the most 
frequently encountered type of myocardial infarction. The patient clinical profile and management has 
evolved over the past decade. As there is still a scarcity of data on the latest trends in NSTEMI, changes 
herein were observed and assessed in the treatment and outcomes in Poland between 2005 and 2014. 
Methods: A total of 197,192 patients with NSTEMI who enrolled in the Polish Registry of Acute Coro-
nary Syndromes (PL-ACS) between 2005 and 2014 were analyzed. In-hospital and 12-month mortality 
were assessed. 
Results: Coronary angiography use increased from 35.8% in 2005–2007 to 90.7% in 2012–2014  
(p < 0.05), whereas percutaneous coronary intervention increased from 25.7% in 2005–2007 to 
63.6% in 2012–2014 (p < 0.05). There was a 50% reduction in in-hospital mortality (from 5.6% in 
2005–2007 to 2.8% in 2012–2014; p < 0.05) and a 30% reduction in 1-year mortality (from 19.4% in 
2005–2007 to 13.7% in 2012–2014; p < 0.05). A multivariate analysis confirmed an immense impact 
of invasive strategy on patient prognosis during in-hospital observation with an odds ratio (OR) of 0.31 
(95% confidence interval [CI] 0.29–0.33; p < 0.05) as well as during the 12-month observation with an 
OR of 0.51 (95% CI 0.49–0.52; p < 0.05). 
Conclusions: Over the past 10 years, an important advance in the management of NSTEMI has taken 
place in Poland. Routine invasive strategy resulted in a significant decrease in mortality rates in all 
groups of NSTEMI patients. (Cardiol J XXXX; XX, X: xx–xx)
Key words: non-ST-elevation myocardial infarction, invasive strategy, percutaneous 
coronary intervention, outcomes, temporal trends
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Introduction
Non-ST-segment elevation myocardial infarc-
tion (NSTEMI) represents the majority of all MI 
cases. In Western Europe, NSTEMI accounts for 
over 60% of all MI cases. Dynamic changes in the 
clinical profile and treatment strategy have been 
observed in recent years. Contemporary analyses 
for a wide national population are scarce.
The analysis of clinical characteristics, treat-
ment strategies and outcomes in almost 200,000 
NSTEMI cases registered in the Polish Registry 
of Acute Coronary Syndromes (PL-ACS) between 
2005 and 2014 are presented.
Methods
The study population was drawn from 463 hos-
pitals in Poland that provide care to patients with 
MIs. The population consists of patients admitted 
with a diagnosis of NSTEMI according to the Eu-
ropean Society of Cardiology guidelines [1, 2]. The 
study covers a 10-year period from 2005 to 2014. 
Contribution to the study was voluntary; neverthe-
less, half of all estimated NSTEMI cases in Poland 
during the study time period were included. The 
study complies with the Declaration of Helsinki and 
was approved by the PL-ACS Registry committee.
Data were collected from PL-ACS Registry 
questionnaires that include variables on demo-
graphic factors (gender, age), risk factors (smok-
ing, hypertension, hypercholesterolemia, diabetes 
mellitus and obesity), previous coronary inci-
dences and related procedures (MI, percutaneous 
coronary intervention [PCI], coronary artery 
bypass grafting), clinical presentation on admission 
(Killip class, heart rate, systolic blood pressure), 
electrocardiographic abnormalities, left ventricu-
lar ejection fraction, coronary angiography (CA), 
coronary intervention details, and in-hospital and 
post-discharge treatment. The mortality rate was 
evaluated for the in-hospital observation period as 
well as for 30-day, 6-month and 12-month follow-
up periods.
Statistical analysis
The gender groups were analyzed separately 
and subsequently compared to each other. To inves-
tigate the impact of age on outcomes, the analysis 
was conducted in age groups (< 55, 55–64, 65–74, 
≥ 75 years) as well as in consecutive decades of 
life. Changes over time were investigated using 
the following two models: a comparison between 
subgroups in marginal 3-year intervals (2005–2007 
and 2012–2014) and an evaluation of temporal 
trends over a 10-year period.
Categorical data are presented as numbers and 
percentages while continuous data are presented as 
the median or arithmetic mean ± standard devia-
tion (SD). Differences in categorical variables were 
tested using the c2 test with Pearson modification, 
whereas in continuous variables differences were 
tested with the Student t-test. A two-sided p value 
≤ 0.05 was considered significant. Trend impor-
tance was verified by the Cochran-Armitage test 
for categorical data and the Jonckheere-Terpstra 
test for continuous data. A logistic regression 
was used to identify variables that independently 
contributed to mortality.
Results
A total of 197,192 patients (including 77,550 
women, 39.3%) hospitalized in Poland due to 
NSTEMI between 2005 and 2014 were included in 
the analysis. The contribution of younger patients 
(under 55) decreased compared to older patients. 
The average age of males increased from 65 to 66 
while in women it was stable at 72. Nevertheless, 
men predominated in the group under 70, whereas 
women did in the group over 70. 
The frequency of diabetes, arterial hyperten-
sion, obesity (in men only), and smoking (in women 
only) also increased. A history of prior coronary 
artery interventions (especially PCI) was more 
common in the later years were observed in this 
study (Table 1).
Over the last decade, NSTEMI treatment 
strategy has changed significantly. The frequency 
of coronary angiography increased from 35.8% in 
2005–2007 up to 90.7% in 2012–2014; p < 0.05. 
From 2012 to 2014, the gender disparity in CA im-
plementation was still visible with 88.4% in women 
vs. 92.1% in men; p < 0.05. PCI use increased 
from 25.7% in 2005–2007 to 63.6% in 2012–2014; 
p < 0.05. From 2012 to 2014 we achieved 59.6% 
in women and 66.1% in men; p < 0.05. The most 
intensive growth of an invasive procedure use took 
place between 2007 and 2011. In later years, only 
a mild further increase was observed. In 2014, 
only 10.9% of women and 7.1% of men (p < 0.05) 
were treated conservatively. Temporal trends in 
the invasive treatment of NSTEMI patients are 
presented in Figure 1.
The age group analysis revealed that the per-
centage of invasive treatment increased most in the 
oldest patients (over 75 years) and achieved a level 
of 80% in CA and 50% in PCI. Although differences 
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among the age groups diminished during the study, 
a slight disproportion still existed. In all age groups, 
invasive strategies were more widespread in men 
than in woman. Nevertheless, this disproportion 
has decreased in recent years (Fig. 2).
There have been significant changes in pharma-
cotherapy over the last decade, especially in the use 
of antiplatelet agents. The utilization of P2Y12-re-
ceptor blockers substantially increased from 51.0% 
in women and 59.1% in men from 2005 to 2007 
to 92.9% in women and 93.2% in men (p < 0.05). 
Ticlopidine, which was commonly used, was almost 
completely substituted by clopidogrel. In addition, 
during the last years a continuous shift from clopi-
dogrel to ticagrelol or prasugrel was observed. 
The management outcomes of NSTEMI pa-
tients have improved considerably over the last 
decade. In the present analysis, the risk of reinfarc-
tion was reduced from 4.5% in 2005–2007 to 0.3% 
in 2012–2014 (p < 0.05), and the risk of stroke 
was reduced from 0.5% in 2005–2007 to 0.2% in 
2012–2014 (p < 0.05). On the other hand, a side 
effect of the intensive invasive treatment applica-
tion was observed, especially in the frequency of 
Table 1. Clinical characteristics of non-ST-elevation myocardial infarction patients.
Clinical characteristics 2005–2007 2012–2014 2005–2007  
vs. 2012–2014
Women Men P Women Men P Women Men
Age < 55 years 1738  
(7.5%)
6162 
(18.6%)
< 0.05 1647  
(6.4%)
5468 
(13.3%)
< 0.05 < 0.05 < 0.05
Age ≥ 7 years 11208  
(48.3%)
8746 
(26.4%)
< 0.05 12098 
(47.4%)
11571 
(28.1%)
< 0.05 < 0.05 < 0.05
Hypertension 17908  
(77.2%)
22792 
(68.8%)
< 0.05 20568 
(80.5%)
31219 
(75.9%)
< 0.05 < 0.05 < 0.05
Diabetes 8180  
(35.3%)
9623 
(23.7%)
< 0.05 7865  
(37.3%)
11999 
(29.2%)
< 0.05 < 0.05 < 0.05
Hyperlipidemia 10182  
(43.9%)
11264 
(43.6%)
0.43 1446  
(44.1%)
18067 
(43.9%)
0.67 0.67 0.33
Current smoking 2403  
(10.4%)
10595 
(32.0%)
< 0.05 3340  
(13.1%)
10989 
(26.7%)
< 0.05 < 0.05 < 0.05
Obesity 5879  
(25.4%)
5143 
(15.5%)
< 0.05 6391  
(25.0%)
7807 
(19.0%)
< 0.05 0.40 < 0.05
Prior MI 5899  
(25.4%)
10097 
(30.5%)
< 0.05 5681  
(22.2%)
10728 
(26.1%)
< 0.05 < 0.05 < 0.05
Prior PCI 736  
(3.2%)
1680 
(5.1%)
< 0.05 4301  
(16.8%)
8534 
(20.8%)
< 0.05 < 0.05 < 0.05
Prior CABG 1321  
(5.7%)
2764 
(8.3%)
< 0.05 1092  
(4.3%)
2755 
(6.7%)
< 0.05 < 0.05 < 0.05
CABG — coronary artery bypass grafting; MI — myocardial infarction; PCI — percutaneous coronary intervention
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Figure 1. Temporal trends in utilization of coronary angi-
ography (CA) (A) and percutaneous coronary interven-
tion (PCI) (B).
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major bleeding (0.7% in 2005–2007 vs. 1.2% in 
2012–2014; p < 0.05). 
In-hospital mortality decreased by 50% (from 
5.6% in 2005–2007 to 2.8% in 2012–2014; p < 0.05) 
and 1-year mortality by up to 30% (from 19.4% in 
2005–2007 to 13.7% in 2012–2014; p < 0.05) (Fig. 3). 
These positive tendencies are apparent in all age 
groups and genders (Table 2). Mortality rates in 
the four age groups (under 55, 55–64, 65–74, 75 
and over) are presented in Figure 4. 
A multivariable analysis showed that the impact 
of the invasive strategy on mortality decrease was 
immense, with a 3-fold improvement in outcomes 
in short-term observation and a 2-fold improvement 
in long-term observation (Tables 3 and 4). 
Discussion
The clinical characteristics and management 
of NSTEMI patients together with treatment 
Figure 2. Percentage of coronary angiography (CA) (A) 
and percutaneous coronary intervention (PCI) (B) in age 
groups.
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Figure 3. Temporal trends of in-hospital mortality (A) 
and 12-month mortality (B).
Table 2. Mortality rates by gender.
Mortality rates 2005–2007 2012–2014 2005–2007  
vs. 2012–2014
Women Men P Women Men P Women Men
In-hospital mortality 1541  
(6.6%)
1633 
(4.9%)
< 0.05 851  
(3.3%)
1026 
(2.5%)
< 0.05 < 0.05 < 0.05
30-day mortality 2267  
(9.8%)
2571 
(7.8%)
< 0.05 1686  
(6.6%)
2101 
(5.1%)
< 0.05 < 0.05 < 0.05
6-month mortality 3988  
(17.2%)
4586 
(13.8%)
< 0.05 2997  
(11.7%)
3994 
(9.7%)
< 0.05 < 0.05 < 0.05
12-month mortality 5005  
(21.6%)
5897 
(17.8%)
< 0.05 3865  
(15.1%)
5258 
(12.8%)
< 0.05 < 0.05 < 0.05
0%
20%
40%
60%
p < 0.05 for all
A
B
2005–2007 Men2005–2007 Women
2012–2014 Men2012–2014 Women
80%
100%
110%
< 55 years 55–64 years 65–74 years ≥ 75 years
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outcomes have significantly changed all over the 
world in recent years [3–5]. In Poland, as in many 
other countries, NSTEMI has become the most 
common type of MI.
According to many previous reports on NSTE-
MI, there are common trends in the baseline clini-
cal profile of patients. The prevalence of major ath-
erosclerosis risk factors like arterial hypertension, 
diabetes, obesity and chronic kidney disease is still 
increasing [4, 5]. Similar trends were observed in 
the present study. Contrary to findings in other 
countries, the mean age of NSTEMI patients in 
Poland increased, especially in men. Presumably 
this is a result of a noticeable smoking decrease 
and better pharmacological risk factor control, i.e., 
hypercholesterolemia and arterial hypertension. 
Over the last 10 years, some important changes 
in medical therapy have taken place. The vast 
majority of patients received P2Y12-receptor 
blockers. Interestingly, from 2005 to 2007 many 
patients were still administered ticlopidine, which 
was gradually substituted by clopidogrel and later 
by new drugs such as ticagrelol, according to the 
European Society of Cardiology guidelines [1, 2].
Figure 4. In-hospital mortality (A) and 12-month mortal-
ity (B) in age groups.
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Table 3. Multivariate analysis (in-hospital mortality).
P OR OR (95% CI)
Invasive treatment < 0.0001 0.31 0.31 (0.29–0.33)
Hypercholesterolemia < 0.0001 0.73 0.73 (0.69–0.77)
Hypertension < 0.0001 0.73 0.73 (0.69–0.78)
Previous PCI < 0.0001 0.80 0.80 (0.73–0.88)
Previous CABG 0.0006 0.80 0.80 (0.71–0.91)
Current smokers 0.6776 1.02 1.02 (0.94–1.10)
Female (vs. male) 0.4485 1.02 1.02 (0.97–1.08)
Previous MI 0.0255 1.07 1.07 (1.01–1.14)
Diabetes 0.0021 1.09 1.09 (1.03–1.15)
Time to admission > 12 h 0.0030 1.09 1.09 (1.03–1.16)
LVEF 35–50% 0.0240 1.10 1.10 (1.01–1.20)
ST-T abnormalities in ECG 0.0007 1.16 1.16 (1.07–1.27)
Obesity < 0.0001 1.18 1.18 (1.10–1.26)
No sinus rhythm in ECG < 0.0001 1.19 1.19 (1.12–1.27)
Age (on each decade) < 0.0001 1.63 1.63 (1.59–1.68)
LVEF < 35% < 0.0001 2.31 2.31 (2.11–2.53)
Prehospital cardiac arrest < 0.0001 2.37 2.37 (2.09–2.69)
Killip 3 class < 0.0001 3.67 3.67 (3.41–3.94)
IABP < 0.0001 3.89 3.89 (3.23–4.69)
Killip 4 class < 0.0001 13.17 13.2 (12.0–14.4)
CABG — coronary artery bypass grafting; CI — confidence interval; ECG — electrocardiogram; IABP — intraaortic balloon pump; LVEF — left 
ventricular ejection fraction; MI — myocardial infarction; OR — odds ratio; PCI — percutaneous coronary intervention
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Table 4. Multivariate analysis (12-month mortality).
P OR OR (95% CI)
Invasive treatment < 0.0001 0.51 0.51 (0.49–0.52)
Hypercholesterolemia < 0.0001 0.81 0.81 (0.79–0.83)
Previous CABG < 0.0001 0.84 0.84 (0.80–0.88)
Hypertension < 0.0001 0.85 0.85 (0.83–0.88)
Previous PCI < 0.0001 0.90 0.90 (0.87–0.94)
Female (vs. male) < 0.0001 0.94 0.94 (0.92–0.97)
Obesity 0.37 0.99 0.99 (0.96–1.02)
Time to admission > 12 h 0.02 1.02 1.03 (1.00–1.06)
Current smokers 0.0005 1.07 1.06 (1.03–1.10)
Previous MI < 0.0001 1.12 1.12 (1.09–1.15)
ST-T abnormalities in ECG < 0.0001 1.14 1.15 (1.11–1.19)
No sinus rhythm in ECG < 0.0001 1.15 1.14 (1.11–1.18)
Diabetes < 0.0001 1.29 1.29 (1.26–1.32)
LVEF 35–50% < 0.0001 1.52 1.52 (1.47–1.57)
Age (on each decade) < 0.0001 1.57 1.57 (1.55–1.59)
Prehospital cardiac arrest < 0.0001 1.74 1.74 (1.63–1.85)
Killip 3 class < 0.0001 1.98 1.98 (1.91–2.06)
IABP < 0.0001 2.17 2.17 (1.99–2.38)
LVEF < 35% < 0.0001 2.67 2.67 (2.57–2.78)
Killip 4 class < 0.0001 4.48 4.48 (4.26–4.71) 
CABG — coronary artery bypass grafting; CI — confidence interval; ECG — electrocardiogram; IABP — intraaortic balloon pump; LVEF — left 
ventricular ejection fraction; MI — myocardial infarction; OR — odds ratio; PCI — percutaneous coronary intervention
The European Society of Cardiology-rec-
ommended implementation of a routine invasive 
strategy has been the most important change in 
NSTEMI treatment over the last 10 years [1, 2]. A 
rapid increase in the number of 24/7 catheterization 
centers in Poland (up to 150) enabled the successful 
introduction of this recommendation. The percent-
age of CAs as well as PCIs in NSTEMI patients 
in Poland reached the same level as countries in 
Western Europe such as France [4] and Denmark 
[6] as well as the United States [5]. Importantly, 
previously reported underutilization of an invasive 
strategy in women as well as in older patients was 
not as pronounced in Poland [7–11]. The significant 
advances in treatment have resulted in a spectacu-
lar decrease in mortality rates at an even higher 
rate than in previous analyses [3–5, 12, 13]. 
In the multivariable analysis, the invasive 
strategy was the most important factor contributing 
to a better prognosis for in-hospital and 12-month 
observations. The advantages of invasive treat-
ment were apparent in all patients regardless of 
age or gender. The final results are comparable to 
data from other countries that have successfully 
introduced contemporary guidelines [14].
Limitations of the study
This study has several limitations. PL-ACS is a 
voluntary, observational study, and not all hospitals 
treating NSTEMI in Poland participated in data 
collection. The present analysis was retrospec-
tive, and some potentially important parameters 
might not be included. Finally, this is a single 
country study; therefore, some trends should be 
interpreted with caution. 
Conclusions
In Poland, outcomes of NSTEMI patients have 
improved substantially over the last 10 years due 
to the implementation of routine invasive treat-
ment. The invasive approach was beneficial to all 
age groups and both genders. 
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